Southeastern Clinical Research Institute, LLC

Augusta, Georgia 30909

1 studies enrolling now · 13 studies all time

What they study most

ADPKD, Autosomal Dominant Polycystic Kidney Disease, Cardiovascular Risk, Chronic Kidney Disease, Chronic Kidney Diseases, Diabetes Mellitus, Type 2, End-Stage Renal Disease (ESRD), IgA Nephropathy, Inflammation, Iron Deficiency Anemia, Kidney Diseases, Non-diabetic Chronic Kidney Disease

Studies at this site

• Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy — Recruiting now
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease — Completed
• A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease — Completed
• Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition — Completed
• Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD) — Stopped early
• A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease — Completed
• A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease — Completed
• Quanta Home Run Trial — Completed
• A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD) — Completed
• Renasight Clinical Application, Review and Evaluation (RenaCARE) Study — Status unconfirmed
• KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial) — Completed
• Efficacy and Safety of Atacicept in IgA Nephropathy — Stopped early